To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307

Clinical trial NCT05783570 · UNKNOWN

Trial details

NCT number: NCT05783570
Sponsor: Eutilex
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma

Start date: 2023-08-24
Primary completion: 2025-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.